<p>Kimberly-Clark (NASDAQ:KMB) is preparing to release its quarterly earnings on Tuesday, 2026-01-27. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Kimberly-Clark to report an <strong>earnings per share</strong> (EPS) of $1.64.</p>
<p>Kimberly-Clark bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings Track Record</h3>
<p>The company's EPS beat by $0.19 in the last quarter, leading to a 0.42% drop in the share price on the following day.</p>
<p>Here's a look at Kimberly-Clark's past performance and the resulting price change:</p>
<p></p><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">1.63</td>
<td align="right">1.67</td>
<td align="right">1.89</td>
<td align="right">1.51</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">1.82</td>
<td align="right">1.92</td>
<td align="right">1.93</td>
<td align="right">1.50</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">0.00</td>
<td align="right">5.00</td>
<td align="right">-3.00</td>
<td align="right">0.00</td>
</tr>
</tbody>
</table><p></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769439655_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" width="700" height="500" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769439655_0.png"/></p>

<h3>Performance of Kimberly-Clark Shares</h3>
<p>Shares of Kimberly-Clark were trading at $102.23 as of January 23. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Insights Shared by Analysts on Kimberly-Clark</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Kimberly-Clark.</p>
<p>Analysts have provided Kimberly-Clark with 14 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $113.57, suggesting a potential 11.09% upside.</p>
<h3>Analyzing Ratings Among Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Church &amp; Dwight Co, Clorox and Reynolds Consumer Prods, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Church &amp; Dwight Co, with an average 1-year price target of $94.89, suggesting a potential 7.18% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Clorox, with an average 1-year price target of $113.18, suggesting a potential 10.71% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Reynolds Consumer Prods, with an average 1-year price target of $26.0, suggesting a potential 74.57% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Church &amp; Dwight Co, Clorox and Reynolds Consumer Prods are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p></p><table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>0.14%</td>
<td>$1.49B</td>
<td>34.27%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Buy</td>
<td>4.96%</td>
<td>$714.40M</td>
<td>4.23%</td>
</tr>
<tr>
<td>Clorox</td>
<td>Neutral</td>
<td>-18.90%</td>
<td>$596M</td>
<td>53.51%</td>
</tr>
<tr>
<td>Reynolds Consumer Prods</td>
<td>Neutral</td>
<td>2.31%</td>
<td>$233M</td>
<td>3.65%</td>
</tr>
</tbody>
</table><p></p>
<p>Key Takeaway:</p>
<p>Kimberly-Clark ranks in the middle for Consensus rating. It is at the bottom for Revenue Growth. It is at the top for Gross Profit. It is at the top for Return on Equity.</p>
<h3>Delving into Kimberly-Clark's Background</h3>
<p>With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.</p>
<h3>Understanding the Numbers: Kimberly-Clark's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Kimberly-Clark showcased positive performance, achieving a revenue growth rate of <strong>0.14%</strong> as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Kimberly-Clark's net margin excels beyond industry benchmarks, reaching <strong>10.75%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>34.27%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.65%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>5.48</strong>, caution is advised due to increased financial risk.</p>
<p>To track all earnings releases for Kimberly-Clark visit their earnings calendar on our site.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>

<p>Kimberly-Clark (NASDAQ:KMB) is set to announce its quarterly earnings on January 27, 2026, with analysts predicting an EPS of $1.64. The company's recent performance shows a mixed track record, with a 20.69% decline in share price over the past year. Analysts rate Kimberly-Clark as Neutral, with a one-year price target of $113.57, indicating an 11.09% upside. The company excels in net margin and return on equity but faces challenges in revenue growth and debt management. Investors should focus on the earnings announcement and guidance for future growth.</p>

Insights Ahead: Kimberly-Clark's Quarterly Earnings